Abstract

Vitiligo is a chronic skin disorder characterised by the loss of melanocytes, leading to depigmented patches that can affect individuals of all ages and skin types. This review examines the multifaceted impact of vitiligo, focusing on its physical, emotional, and psychological consequences. The condition often leads to significant psychosocial burdens, including stigma, social isolation, and mental health challenges such as anxiety and depression. Cultural and societal perceptions can further exacerbate these difficulties, making holistic patient support essential. This review was conducted by systematically searching PubMed, Scopus, and Google Scholar for relevant literature published in English. Keywords included “vitiligo,” “nursing care,” “psychosocial impact,” and “holistic management.” Article were selected based on relevance, with a focus on nursing interventions, treatment strategies, and patient experiences. Data extraction emphasised current evidence, best practices, and emerging trends in vitiligo care.Nurses play a pivotal role in vitiligo management by providing patient-centred care that addresses both physical and emotional well-being. Their responsibilities include educating patients and families on the condition’s causes, progression, and treatment options, such as corticosteroids, phototherapy, and emerging therapies like Janus kinase (JAK) inhibitors. Additionally, nurses facilitate multidisciplinary care by coordinating with dermatologists, psychologists, and other specialists. Ethical considerations, particularly in offering cosmetic interventions to improve quality of life, further shape nursing practice in vitiligo care.Despite medical advancements, challenges persist in healthcare delivery.

• 1.   Mosca S, Morrone A. Human Skin Pigmentation: From a Biological Feature to a Social Determinant. Healthcare (Basel). 2023 Jul 22;11(14): 2091. doi: 10.3390/healthcare11142091. PMID: 37510532; PMCID: PMC10379278.
• 2.   Del Bino S, Duval C, Bernerd F. Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact. Int J Mol Sci. 2018 Sep 8;19(9): 2668. doi: 10.3390/ijms19092668. PMID: 30205563; PMCID: PMC6163216.
• 3.   Grimes PE, Miller MM. Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. Int J Women’s Dermatol. 2018 Jan 8;4(1): 32-37. doi: 10.1016/j.ijwd.2017.11.005. PMID: 29872674; PMCID: PMC5986114.
• 4.   Salama AH, Alnemr L, Khan AR, Alfakeer H, Aleem Z, Ali-Alkhateeb M. Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo’s Psychological, Social, and Quality of Life Impacts. Cureus. 2023 Sep 11;15(9): e45030. doi: 10.7759/cureus.45030. PMID: 37829995; PMCID: PMC10566310.
• 5.   Delgado P, Crumpton K. A practical guide to vitiligo differential diagnoses in primary care. The Nurse Practitioner. 2021 Nov;46(11): 29.
• 6.   Chang WL, Lee WR, Kuo YC, Huang YH. Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention. Front Cell Dev Biol. 2021 Dec 14;9: 797026. doi: 10.3389/fcell.2021.797026. PMID: 34970551; PMCID: PMC8712646.
• 7.   Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev. 2021 Mar;41(2): 1138-1166. doi: 10.1002/med.21754. Epub 2020 Nov 17. PMID: 33200838; PMCID: PMC7983894.
• 8.   Ahmed Jan N, Masood S. Vitiligo. Updated 2023 Aug 7. In: Stat Pearls Internet. Treasure Naseema Shafqat, Malini Mondal, et al. Vitiligo Management Beyond Skin:
• 9.   Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https: //www.ncbi.nlm.nih. gov/books/NBK559149/
• 10.   Very well Health Internet. Cited 2024 Aug 26. The 3 Stages of Vitiligo. Available from: https: //www.verywellhealth.com/vitiligostages-5215686 Vitiligo: Causes, Types, and Treatment —DermNet Internet. Cited 2024 Sep 20. Available from: https: //dermnetnz.org/topics/vitiligo
• 11.   Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A; Vitiligo Global Issue Consensus Conference Panelists. Revised classfcation/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012 May;25(3): E1-13. doi: 10.1111/j.1755-148X.2012.00997.x. PMID: 22417114; PMCID: PMC3511780.
• 12.   Vitiligo - Symptoms & causes - Mayo Clinic Internet. Cited 2024 Sep 20. Available from: https: //www.mayoclinic.org/diseasesconditions/vitiligo/symptoms-causes/syc20355912
• 13.   Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, Pandya AG. Psychosocial Effects of Vitiligo: A Systematic Literature Review. Am J Clin Dermatol. 2021 Nov;22(6): 757-774. doi: 10.1007/s40257-021-00631-6. Epub 2021 Sep 23. PMID: 34554406; PMCID: PMC8566637.
• 14.   MHS KL MD. Harvard Health. 2019 cited 2024 Jul 25. Vitiligo: More than skin deep. Available from: https: //www.health. harvard.edu/blog/vitiligo-more-than-skindeep-2019092617885
• 15.   Hu Z, Wang T. Beyond skin white spots: Vitiligo and associated comorbidities. Front Med (Lausanne). 2023 Feb 23;10: 1072837. doi: 10.3389/fmed.2023.1072837. PMID: 36910477;PMCID: PMC9995999.
• 16.   Maddodi N, Jayanthy A, Setaluri V. Shining light on skin pigmentation: the darker and the brighter side of effects of UV radiation. Photochem Photobiol. 2012 Sep-Oct;88(5): 1075-82. doi: 10.1111/j.1751-1097.2012.01138.x. Epub 2012 Apr 12. PMID: 22404235; PMCID: PMC3400707.
• 17.   Vitiligo: Self-care Internet. Cited 2024 Aug 27. Available from: https: //www.aad.org/public/diseases/a-z/vitiligo-self-care
• 18.   Feng Z, Qin Y, Jiang G. Reversing Gray Hair: Inspiring the Development of New Therapies hrough Research on Hair Pigmentation and Repigmentation Progress. Int J Biol Sci. 2023 Aug 28;19(14): 4588-4607. doi: 10.7150/ijbs.86911. PMID: 37781032; PMCID: PMC10535703.
• 19.   O’Sullivan JDB, Nicu C, Picard M, Chéret J, Bedogni B, Tobin DJ, Paus R. The biology of human hair greying. Biol Rev Camb Philos Soc. 2021 Feb;96(1): 107-128. doi: 10.1111/brv.12648. Epub 2020 Sep 23. PMID: 32965076.
• 20.   Park AM, Khan S, Rawnsley J. Hair Biology: Growth and Pigmentation. Facial Plast Surg Clin North Am. 2018 Nov;26(4): 415-424. doi: 10.1016/j.fsc.2018.06.003. Epub 2018 Aug 16. PMID: 30213423.
• 21.   Verywell Health Internet. Cited 2024 Aug 27. Vitiligo Hair: Symptoms, Treatment, and Causes. Available from: https: //www.verywellhealth.com/vitiligo-hair-5221221
• 22.   Farhud DD. Impact of Lifestyle on Health. Iran J Public Health. 2015 Nov;44(11): 1442-4. PMID: 26744700; PMCID: PMC4703222.
• 23.   Mahama AN, Haller CN, Ahmed AM. Psychosocial considerations in the management of vitiligo. Clinics in Dermatology. 2023 Jan 1;41(1): 82–8.
• 24.   Salama AH, Alnemr L, Khan AR, Alfakeer H, Aleem Z, Ali-Alkhateeb M. Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo’s Psychological, Social, and Quality of Life Impacts. Cureus. 15(9): e45030.
• 25.   Vitiligo: A Patch on Skin and the Mind | SpringerLink Internet. Cited 2024 Sep 26. Available from: https: //link.springer.com/chapter/10.1007/978-981-97-0411-8_13
• 26.   Augustin M, Gewiss C, Ben-Anaya N, Böhm M. Lebensqualität, Krankheitslast und Versorgungsbedarf von Patienten mit Vitiligo Quality of life, disease burden and healthcare need of patients with vitiligo. Dermatologie (Heidelb). 2024 May;75(5): 404-411. German. doi: 10.1007/s00105-024-05312-z. Epub 2024 Mar 11. PMID: 38466405; PMCID: PMC11065915.
• 27.   Bibeau K, Ezzedine K, Harris JE, Geel N van, Grimes P, Parsad D, et al. Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo. cited 2024 Sep 26; Available from: https: //jamanetwork.c o m / j o u r n a l s / j a m a d e r m a t o l o g y /fullarticle/2808976 117CPHN / Volume 10 Number 2/May - August 2025
• 28.   Rosmarin D, Soliman AM, Piercy J, Marwaha S, Anderson P, Camp HS. Health-Related Quality of Life Burden among Adults with Vitiligo: Relationship to Disease Severity and Disease Location. Dermatol Ther (Heidelb). 2024 Jun;14(6): 1633-1647. doi: 10.1007/s13555-024-01187-z. Epub 2024 Jun 2. PMID: 38824482;PMCID: PMC11169145.

Data Sharing Statement

Funding